Requirements for growth and IL-10 expression of highly purified human T regulatory cells

B Bonacci, B Edwards, S Jia, CB Williams… - Journal of clinical …, 2012 - Springer
B Bonacci, B Edwards, S Jia, CB Williams, MJ Hessner, SB Gauld, JW Verbsky
Journal of clinical immunology, 2012Springer
Human regulatory T cells (TR) cells have potential for the treatment of a variety of immune
mediated diseases but the anergic phenotype of these cells makes them difficult to expand
in vitro. We have examined the requirements for growth and cytokine expression from highly
purified human TR cells, and correlated these findings with the signal transduction events of
these cells. We demonstrate that these cells do not proliferate or secrete IL-10 even in the
presence of high doses of IL-2. Stimulation with a superagonistic anti-CD28 antibody (clone …
Abstract
Human regulatory T cells (TR) cells have potential for the treatment of a variety of immune mediated diseases but the anergic phenotype of these cells makes them difficult to expand in vitro. We have examined the requirements for growth and cytokine expression from highly purified human TR cells, and correlated these findings with the signal transduction events of these cells. We demonstrate that these cells do not proliferate or secrete IL-10 even in the presence of high doses of IL-2. Stimulation with a superagonistic anti-CD28 antibody (clone 9.3) and IL-2 partially reversed the proliferative defect, and this correlated with reversal of the defective calcium mobilization in these cells. Dendritic cells were effective at promoting TR cell proliferation, and under these conditions the proliferative capacity of TR cells was comparable to conventional CD4 lymphocytes. Blocking TGF-β activity abrogated IL-10 expression from these cells, while addition of TGF-β resulted in IL-10 production. These data demonstrate that highly purified populations of TR cells are anergic even in the presence of high doses of IL-2. Furthermore, antigen presenting cells provide proper co-stimulation to overcome the anergic phenotype of TR cells, and under these conditions they are highly sensitive to IL-2. In addition, these data demonstrate for the first time that TGF-β is critical to enable human TR cells to express IL-10.
Springer